The effect of Didronel, a bisphosphonate, ehtylhydroxydiphosphonets (EHDP), is to prevent calcium from being deposited in the bony matrix that has already been formed. EHDP (Didronel) does this by inhibiting the conversion of amorphous calcium phosphate to hydroxyapatite crystals which prevents mineralization of the bone matrix. Therefore, it is essential to make the diagnosis as soon as possible (preferably before any calcium shows up on x-ray) and start the Didronel immediately. Didronel will do nothing to remove calcium that has already been deposited. It is a preventative drug, and has no effect on existing ossification. It also has no effect on the underlying process which produces the bony matrix. There are no known side effects that would prohibit usage.posted by jamjam at 1:42 PM on December 29, 2012
You are not logged in, either login or create an account to post comments
posted by dfriedman at 8:24 AM on December 29, 2012 [1 favorite]